With a market capitalization (market cap) of $121.1B — a measure of how much the company is worth — CVS Health Corp. is the 131st most valuable company in Healthcare as of August 18, 2026. Shares trade at $94.91, up +0.96% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Visit websiteAs of August 18, 2026, CVS Health Corp. (CVS) is worth $121.1B — this is its market capitalization, the total value of all its outstanding shares.
CVS Health Corp.’s market cap is $121.1B, which ranks it #131 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
CVS Health Corp. (CVS) shares trade at $94.91, up 0.96% on the day, as of August 18, 2026.
CVS Health Corp. trades at a price-to-earnings (P/E) ratio of 67.8, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025